Home / Stocks / ACXP

ACXP insider trading

Acurx Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$171k
Buys · last 90 days
0 · $0
Most recent buy
2025-01-08

Cluster buy detected

6 insiders bought ACXP within a short window (2025-01-06), $171k in total — cluster score 49/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-01-08Scodari Joseph Ccluster
Director
Bought24,631$1.02$25k
2025-01-08Sailer Carlcluster
Director
Bought24,631$1.02$25k
2025-01-08LUCI DAVID Pcluster
President and CEO
Bought49,261$1.02$50k
2025-01-08Donohue James J.cluster
Director
Bought9,852$1.02$10k
2025-01-08DELUCCIA ROBERT Jcluster
Director · 10% owner
Bought49,261$1.02$50k
2025-01-08DEAN JACK Hcluster
Director
Bought9,852$1.02$10k

Most active insider buyers

InsiderRoleBuysTotal bought
LUCI DAVID PPresident and CEO1$50k
DELUCCIA ROBERT JDirector · 10% owner1$50k
Scodari Joseph CDirector1$25k
Sailer CarlDirector1$25k
Donohue James J.Director1$10k
DEAN JACK HDirector1$10k

See ACXP on the chart

Every insider buy and sell for ACXP plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.